https://news.medxy.ai/zh/explainable-ai-oct-outcome-prediction/Medxy AIzh2026-10-17T10:15:41-07:00用可解释AI驱动的OCT生物标志物预测中心性浆液性脉络膜视网膜病变结局：来自多中心队列研究的启示 https://news.medxy.ai/ja/interpretable-ai-retinopathy-prognosis/Medxy AIja2026-10-17T10:15:24-07:00解釈可能AIで読み解く中心性漿液性脈絡網膜症の予後予測：多施設コホート研究からの知見 https://news.medxy.ai/vi/central-serous-retinopathy-prediction/Medxy AIvi2026-10-17T10:15:01-07:00Dự đoán diễn tiến bệnh lý hắc võng mạc trung tâm thanh dịch bằng AI có khả năng diễn giải từ biomarker OCT: Kết quả từ một nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/zh/facial-synkinesis-phenotypes/Medxy AIzh2026-10-17T10:14:03-07:00面部联动异常静息期表型分层：对手术规划的启示 https://news.medxy.ai/ja/facial-synkinesis-phenotype/Medxy AIja2026-10-17T10:13:44-07:00顔面連合運動の静止時表現型を読み解く：外科計画への示唆 https://news.medxy.ai/vi/resting-facial-synergies/Medxy AIvi2026-10-17T10:13:15-07:00Ba kiểu hình đồng vận mặt lúc nghỉ: Gợi ý quan trọng cho lập kế hoạch phẫu thuật https://news.medxy.ai/zh/muscle-recovery-assessment/Medxy AIzh2026-10-17T04:09:11-07:00评估肌肉恢复：K-Force 握力测力计在 ICU 获得性无力患者中的反应性 https://news.medxy.ai/ja/muscle-recovery-responsiveness-of-the-k-force-grip-dynamometer/Medxy AIja2026-10-17T04:08:52-07:00筋回復の評価：ICU獲得性筋力低下患者におけるK-Force握力計の反応性 https://news.medxy.ai/vi/hand-grip-strength/Medxy AIvi2026-10-17T04:08:27-07:00Đánh giá phục hồi cơ: khả năng đáp ứng của máy đo lực bóp tay K-Force ở bệnh nhân yếu cơ ICU https://news.medxy.ai/assessing-muscle-recovery-responsiveness-of-the-k-force-grip-dynamometer-in-icu-acquired-weakness-patients/Medxy AIen2026-10-17T04:08:03-07:00Assessing Muscle Recovery: Responsiveness of the K-Force Grip Dynamometer in ICU-Acquired Weakness Patients https://news.medxy.ai/zh/long-acting-injection-hiv/Medxy AIzh2026-10-17T04:07:28-07:00每8周一次长效注射卡博特韦-利匹韦林用于撒哈拉以南非洲HIV感染青少年：来自LATA试验及当代证据的启示 https://news.medxy.ai/ja/hiv-long-acting-injection/Medxy AIja2026-10-17T04:07:00-07:00サハラ以南アフリカのHIV陽性思春期における8週間ごとの長時間作用型注射製剤カボテグラビル／リルピビリン：LATA試験と最新の臨床的意義 https://news.medxy.ai/vi/cabotegravir-injections/Medxy AIvi2026-10-17T04:06:27-07:00Cabotegravir-rilpivirine dạng tiêm tác dụng kéo dài mỗi 8 tuần cho thanh thiếu niên nhiễm HIV ở khu vực hạ Sahara châu Phi: Bằng chứng từ thử nghiệm LATA và bối cảnh hiện nay https://news.medxy.ai/long-acting-injectable-cabotegravir-rilpivirine-every-8-weeks-for-adolescents-with-hiv-in-sub-saharan-africa-evidence-from-the-lata-trial-and-contemporary-context/Medxy AIen2026-10-17T04:05:55-07:00Long-Acting Injectable Cabotegravir-Rilpivirine Every 8 Weeks for Adolescents with HIV in Sub-Saharan Africa: Evidence from the LATA Trial and Contemporary Context https://news.medxy.ai/zh/antibiotic-optimization/Medxy AIzh2026-10-17T04:04:56-07:00合并医疗复杂性患儿社区获得性肺炎的抗生素优化：窄谱治疗更有证据支持 https://news.medxy.ai/ja/pediatric-pneumonia-treatment/Medxy AIja2026-10-17T04:04:36-07:00医療的複雑性を有する小児の市中肺炎治療最適化：狭域抗菌薬使用を支持するエビデンス https://news.medxy.ai/vi/optimized-antibiotic-treatment/Medxy AIvi2026-10-17T04:04:24-07:00Tối ưu hóa điều trị kháng sinh cho viêm phổi mắc phải trong cộng đồng ở trẻ em có bệnh lý phức tạp: Bằng chứng ủng hộ kháng sinh phổ hẹp https://news.medxy.ai/optimizing-antibiotic-therapy-for-community-acquired-pneumonia-in-children-with-medical-complexity-evidence-for-narrow-spectrum-use/Medxy AIen2026-10-17T04:04:04-07:00Optimizing Antibiotic Therapy for Community-Acquired Pneumonia in Children with Medical Complexity: Evidence for Narrow-Spectrum Use https://news.medxy.ai/zh/scleroderma-chromosome-abnormalities/Medxy AIzh2026-10-17T04:03:25-07:00系统性硬化症中表型特异性的嵌合性染色体异常：对疾病亚型与临床结局的启示 https://news.medxy.ai/ja/systemic-sclerosis-mosaic-chromosomes/Medxy AIja2026-10-17T04:03:04-07:00全身性強皮症における表現型別モザイク染色体異常――病型と臨床転帰への示唆 https://news.medxy.ai/vi/mosaic-chromosome-variants/Medxy AIvi2026-10-17T04:02:41-07:00Biến đổi nhiễm sắc thể dạng khảm đặc hiệu theo kiểu hình trong xơ cứng bì hệ thống: Hàm ý đối với phân nhóm bệnh và kết cục lâm sàng https://news.medxy.ai/phenotype-specific-mosaic-chromosomal-alterations-in-systemic-sclerosis-implications-for-disease-subtypes-and-clinical-outcomes/Medxy AIen2026-10-17T04:02:18-07:00Phenotype-Specific Mosaic Chromosomal Alterations in Systemic Sclerosis: Implications for Disease Subtypes and Clinical Outcomes https://news.medxy.ai/zh/donor-ischemia-biliary-complications/Medxy AIzh2026-10-17T04:01:39-07:00供体热缺血时间对腹腔镜供体右半肝切除术后胆道并发症的影响：一项回顾性队列研究 https://news.medxy.ai/ja/donor-warm-ischemia/Medxy AIja2026-10-17T04:01:20-07:00腹腔鏡下生体ドナー右肝切除におけるドナー温虚血時間は胆道合併症にどう影響するか：後ろ向きコホート研究からの知見 https://news.medxy.ai/vi/warm-ischemia-time-effects/Medxy AIvi2026-10-17T04:00:57-07:00Ảnh hưởng của thời gian thiếu máu ấm của người hiến đến biến chứng đường mật sau cắt gan phải từ người hiến bằng nội soi: Phát hiện từ một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/impact-of-donor-warm-ischemic-time-on-biliary-complications-after-laparoscopic-donor-right-hepatectomy-insights-from-a-retrospective-cohort-study/Medxy AIen2026-10-17T04:00:34-07:00Impact of Donor Warm Ischemic Time on Biliary Complications After Laparoscopic Donor Right Hepatectomy: Insights From a Retrospective Cohort Study https://news.medxy.ai/vi/compass-scc-prediction/Medxy AIvi2026-10-17T03:59:14-07:00COMPASS-SCC: Hệ thống tiên lượng và phân giai đoạn mới giúp phân tầng nguy cơ tốt hơn trong ung thư biểu mô tế bào vảy da https://news.medxy.ai/compass-scc-a-novel-prognostic-and-staging-system-enhancing-risk-stratification-in-cutaneous-squamous-cell-carcinoma/Medxy AIen2026-10-17T03:58:52-07:00COMPASS-SCC: A Novel Prognostic and Staging System Enhancing Risk Stratification in Cutaneous Squamous Cell Carcinoma https://news.medxy.ai/zh/diep-reconstruction-effects/Medxy AIzh2026-10-17T03:58:16-07:00既往假体重建与放疗对延迟性DIEP皮瓣乳房重建微血管结局的影响 https://news.medxy.ai/ja/microvascular-outcomes-in-delayed-diep-flap-breast-reconstruction/Medxy AIja2026-10-17T03:57:57-07:00既往のインプラント再建および放射線療法が、遅延型DIEP皮弁乳房再建の微小血管成績に及ぼす影響 https://news.medxy.ai/vi/implant-radiation-effects/Medxy AIvi2026-10-17T03:57:36-07:00Ảnh hưởng của tái tạo dựa trên implant và xạ trị trước đó đối với kết quả vi mạch trong tái tạo vú trì hoãn bằng vạt DIEP https://news.medxy.ai/impact-of-prior-implant-based-reconstruction-and-radiotherapy-on-microvascular-outcomes-in-delayed-diep-flap-breast-reconstruction/Medxy AIen2026-10-17T03:57:16-07:00Impact of Prior Implant-Based Reconstruction and Radiotherapy on Microvascular Outcomes in Delayed DIEP Flap Breast Reconstruction https://news.medxy.ai/zh/cyp2d6-cyp2c19-vnlafaxine-impact/Medxy AIzh2026-10-17T03:56:41-07:00CYP2D6 与 CYP2C19 遗传变异对文拉法辛疗效的影响：来自挪威和英国队列的研究洞见 https://news.medxy.ai/ja/cyp2d6-cyp2c19-genetics-impact/Medxy AIja2026-10-17T03:56:20-07:00CYP2D6・CYP2C19遺伝子多型がベンラファキシン治療成績に与える影響：ノルウェー・英国コホートからの知見 https://news.medxy.ai/vi/cyp2d6-and-cyp2c19-genetic-variations-on-venlafaxine-treatment-outcomes/Medxy AIvi2026-10-17T03:55:57-07:00Ảnh hưởng của các biến thể di truyền CYP2D6 và CYP2C19 đến hiệu quả của Venlafaxine https://news.medxy.ai/impact-of-cyp2d6-and-cyp2c19-genetic-variations-on-venlafaxine-treatment-outcomes-insights-from-norwegian-and-uk-cohorts/Medxy AIen2026-10-17T03:55:37-07:00Impact of CYP2D6 and CYP2C19 Genetic Variations on Venlafaxine Treatment Outcomes: Insights from Norwegian and UK Cohorts https://news.medxy.ai/zh/ecmo-inotropes-impact/Medxy AIzh2026-10-17T03:55:02-07:00VA ECMO 支持期间持续使用正性肌力药对结局的影响 https://news.medxy.ai/ja/va-ecmo-inotropic-effects/Medxy AIja2026-10-17T03:54:41-07:00心原性ショックに対するVA ECMO補助中の強心薬長期使用が転帰に及ぼす影響 https://news.medxy.ai/vi/va-ecmo-cardiac-shock/Medxy AIvi2026-10-17T03:54:18-07:00Tác động của việc sử dụng thuốc tăng co bóp tim kéo dài lên kết cục trong hỗ trợ VA ECMO ở sốc tim https://news.medxy.ai/impact-of-prolonged-inotropic-use-on-outcomes-during-va-ecmo-support-in-cardiogenic-shock/Medxy AIen2026-10-17T03:53:54-07:00Impact of Prolonged Inotropic Use on Outcomes During VA ECMO Support in Cardiogenic Shock https://news.medxy.ai/zh/outpatient-documentation-efficiency/Medxy AIzh2026-10-17T03:53:18-07:00门诊文书标准化提升内科住院医师效率：对时间、病历质量与倦怠的影响 https://news.medxy.ai/ja/standardizing-clinical-records/Medxy AIja2026-10-17T03:53:01-07:00外来診療記録の標準化で内科レジデントの業務効率を高める：所要時間・記載品質・バーンアウトへの影響 https://news.medxy.ai/vi/outpatient-documentation/Medxy AIvi2026-10-17T03:52:39-07:00Chuẩn hóa ghi chép ngoại trú: nâng cao hiệu quả cho bác sĩ nội trú Nội khoa, tác động lên thời gian, chất lượng ghi chú và kiệt sức https://news.medxy.ai/enhancing-internal-medicine-resident-efficiency-through-outpatient-documentation-standardization-effects-on-time-note-quality-and-burnout/Medxy AIen2026-10-17T03:52:18-07:00Enhancing Internal Medicine Resident Efficiency through Outpatient Documentation Standardization: Effects on Time, Note Quality, and Burnout https://news.medxy.ai/zh/innovative-anticoagulants/Medxy AIzh2026-10-17T03:51:45-07:00创新抗凝新方向：靶向凝血因子XI的 Amrecibart 与 Cenvacibart，助力更安全的血栓预防 https://news.medxy.ai/ja/factor-xi-antibodies/Medxy AIja2026-10-17T03:51:26-07:00出血リスク低減をめざす新規抗凝固戦略：Factor XI標的抗体amrecibartとcenvacibart https://news.medxy.ai/vi/factor-xi-with-amrecibart-and-cenvacibart-for-safer-thrombosis-prevention/Medxy AIvi2026-10-17T03:51:06-07:00Chiến lược chống đông máu mới nhằm giảm nguy cơ chảy máu: Các kháng thể nhắm đích Yếu tố XI (Factor XI) là amrecibart và cenvacibart https://news.medxy.ai/innovative-anticoagulation-targeting-factor-xi-with-amrecibart-and-cenvacibart-for-safer-thrombosis-prevention/Medxy AIen2026-10-17T03:50:45-07:00Innovative Anticoagulation: Targeting Factor XI with Amrecibart and Cenvacibart for Safer Thrombosis Prevention https://news.medxy.ai/ja/amikacin-liposome-trial/Medxy AIja2026-10-17T03:50:10-07:00新規診断の Mycobacterium avium complex 肺疾患に対する Amikacin Liposome Inhalation Suspension：第3b相 ENCORE試験 https://news.medxy.ai/vi/amikacin-liposome-trial-2/Medxy AIvi2026-10-17T03:49:47-07:00Hỗn dịch hít amikacin dạng liposome trong bệnh phổi do phức hợp Mycobacterium avium mới được chẩn đoán: Thử nghiệm ENCORE giai đoạn 3b https://news.medxy.ai/amikacin-liposome-inhalation-suspension-in-newly-diagnosed-mycobacterium-avium-complex-lung-disease-phase-3b-encore-trial/Medxy AIen2026-10-17T03:49:26-07:00Amikacin Liposome Inhalation Suspension in Newly Diagnosed Mycobacterium avium Complex Lung Disease: Phase 3b ENCORE Trial https://news.medxy.ai/ja/high-level-disinfection-eye-care/Medxy AIja2026-10-17T03:48:52-07:00再使用可能な眼科用器具に高レベル消毒はいつ必要か――多施設合同ポジションペーパーの要点 https://news.medxy.ai/vi/high-level-disinfection-needed-for-reusable-ophthalmic-devices/Medxy AIvi2026-10-17T03:48:19-07:00Khi nào dụng cụ nhãn khoa tái sử dụng cần được khử khuẩn mức độ cao? Diễn giải các tuyên bố quan điểm từ nhiều hiệp hội https://news.medxy.ai/zh/ophthalmic-instrument-disinfection/Medxy AIzh2026-10-17T03:47:46-07:00可重复使用眼科器械何时需要高水平消毒？多学会立场文件解读 https://news.medxy.ai/when-is-high-level-disinfection-needed-for-reusable-ophthalmic-devices-a-multisociety-position-paper-explained/Medxy AIen2026-10-17T03:47:15-07:00When Is High-Level Disinfection Needed for Reusable Ophthalmic Devices? A Multisociety Position Paper Explained https://news.medxy.ai/zh/ehlers-danlos-airway-obstruction/Medxy AIzh2026-10-17T03:46:21-07:00高可动性Ehlers-Danlos综合征与关节过度活动谱系障碍中的可诱发性喉梗阻：临床相关性与预测因素 https://news.medxy.ai/ja/ehlers-danlos-laryngospasm/Medxy AIja2026-10-17T03:46:01-07:00過可動性エーラス・ダンロス症候群と過可動性スペクトラム障害における誘発性喉頭閉塞：臨床関連と予測因子 https://news.medxy.ai/vi/ehlers-danlos-airway-obstruction-2/Medxy AIvi2026-10-17T03:45:36-07:00Tắc nghẽn thanh quản khởi phát được ở hội chứng Ehlers-Danlos tăng động và rối loạn phổ tăng động khớp: các tương quan lâm sàng và yếu tố dự báo https://news.medxy.ai/inducible-laryngeal-obstruction-in-hypermobile-ehlers-danlos-syndrome-and-hypermobility-spectrum-disorders-clinical-correlates-and-predictors/Medxy AIen2026-10-17T03:45:11-07:00Inducible Laryngeal Obstruction in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Clinical Correlates and Predictors https://news.medxy.ai/zh/early-breast-cancer-surgery/Medxy AIzh2026-10-17T03:44:32-07:00早期乳腺癌腋窝手术减量：SOUND 与 INSEMA 试验在临床实践中的应用 https://news.medxy.ai/ja/axillary-surgery-deescalation/Medxy AIja2026-10-17T03:44:14-07:00早期乳がんにおける腋窩手術の脱エスカレーション：SOUND試験とINSEMA試験を臨床実践へ https://news.medxy.ai/vi/reduce-axillary-surgery/Medxy AIvi2026-10-17T03:43:52-07:00Giảm mức độ can thiệp phẫu thuật hố nách trong ung thư vú giai đoạn sớm: Ứng dụng thử nghiệm SOUND và INSEMA trong thực hành lâm sàng https://news.medxy.ai/de-escalating-axillary-surgery-in-early-breast-cancer-implementing-sound-and-insema-trials-in-clinical-practice/Medxy AIen2026-10-17T03:43:29-07:00De-escalating Axillary Surgery in Early Breast Cancer: Implementing SOUND and INSEMA Trials in Clinical Practice https://news.medxy.ai/zh/neonatal-respiratory-optimization/Medxy AIzh2026-10-17T03:42:52-07:00晚期早产剖宫产后新生儿呼吸适应的优化：产前催产素与地塞米松的作用 https://news.medxy.ai/ja/late-preterm-caesarean-respiration/Medxy AIja2026-10-17T03:42:26-07:00late-preterm帝王切開後の新生児呼吸適応を高める：分娩前オキシトシンとデキサメタゾンの役割 https://news.medxy.ai/vi/respiratory-adaptation-preemies/Medxy AIvi2026-10-17T03:42:00-07:00Cải thiện thích nghi hô hấp sơ sinh sau mổ lấy thai ở trẻ sinh non muộn: Vai trò của oxytocin và dexamethasone trước sinh https://news.medxy.ai/enhancing-neonatal-respiratory-adaptation-after-late-preterm-cesarean-delivery-the-role-of-antenatal-oxytocin-and-dexamethasone/Medxy AIen2026-10-17T03:41:37-07:00Enhancing Neonatal Respiratory Adaptation After Late-Preterm Cesarean Delivery: The Role of Antenatal Oxytocin and Dexamethasone https://news.medxy.ai/zh/target-imphd2-guanine-depletion/Medxy AIzh2026-10-17T03:41:02-07:00靶向 IMPDH2 介导的鸟嘌呤核苷酸耗竭，增强胰腺癌中的 KRAS 抑制 https://news.medxy.ai/ja/kras-inhibition-pancreatic-cancer/Medxy AIja2026-10-17T03:40:40-07:00IMPDH2誘導性グアニンヌクレオチド枯渇を標的にして膵癌におけるKRAS阻害を強化する https://news.medxy.ai/vi/target-guanine-depletion/Medxy AIvi2026-10-17T03:40:16-07:00Nhắm vào cạn kiệt nucleotide guanine do IMPDH2 để tăng cường ức chế KRAS trong ung thư tụy https://news.medxy.ai/targeting-impdh2-induced-guanine-nucleotide-depletion-to-enhance-kras-inhibition-in-pancreatic-cancer/Medxy AIen2026-10-17T03:39:55-07:00Targeting IMPDH2-Induced Guanine Nucleotide Depletion to Enhance KRAS Inhibition in Pancreatic Cancer https://news.medxy.ai/zh/p-tau-217-rates/Medxy AIzh2026-10-17T03:39:18-07:00临床前阿尔茨海默病中不同种族/族裔的血浆磷酸化tau-217水平：对筛查及生物标志物实用性的启示 https://news.medxy.ai/ja/preclinical-alzheimers-tau217/Medxy AIja2026-10-17T03:38:55-07:00前臨床アルツハイマー病における人種・民族別血漿リン酸化tau 217割合：スクリーニングとバイオマーカー有用性への示唆 https://news.medxy.ai/vi/tau-217-phosphorylation-rates/Medxy AIvi2026-10-17T03:38:29-07:00Tỷ lệ tau 217 phosphoryl hóa trong huyết tương theo chủng tộc và sắc tộc ở bệnh Alzheimer tiền lâm sàng: hàm ý cho sàng lọc và giá trị của biomarker https://news.medxy.ai/plasma-phosphorylated-tau-217-percentage-by-race-and-ethnicity-in-preclinical-alzheimer-disease-implications-for-screening-and-biomarker-utility/Medxy AIen2026-10-17T03:38:05-07:00Plasma Phosphorylated Tau 217 Percentage by Race and Ethnicity in Preclinical Alzheimer Disease: Implications for Screening and Biomarker Utility https://news.medxy.ai/zh/adrenal-tumor-cortisol/Medxy AIzh2026-10-17T03:37:15-07:00肾上腺肿瘤中的轻度自主性皮质醇分泌：与精神障碍风险的关联 https://news.medxy.ai/ja/adrenal-tumor-cortisol-mental-health/Medxy AIja2026-10-17T03:36:54-07:00副腎腫瘍患者における軽度自律性コルチゾール分泌と精神疾患の関連を探る https://news.medxy.ai/vi/cortisol-mental-disorders/Medxy AIvi2026-10-17T03:36:30-07:00Tiết cortisol tự chủ nhẹ có liên quan thế nào đến rối loạn tâm thần ở bệnh nhân u tuyến thượng thận? https://news.medxy.ai/exploring-the-link-between-mild-autonomous-cortisol-secretion-and-psychiatric-disorders-in-patients-with-adrenal-tumors/Medxy AIen2026-10-17T03:36:07-07:00Exploring the Link Between Mild Autonomous Cortisol Secretion and Psychiatric Disorders in Patients With Adrenal Tumors https://news.medxy.ai/zh/v-waves-in-heart-failure-with-preserved-ejection-fraction/Medxy AIzh2026-10-17T03:35:28-07:00V波在射血分数保留的心力衰竭中作用：在右心室后负荷及肺血管评估中的作用 https://news.medxy.ai/ja/v-waves-in-heart-failure-preserved-ejection-fraction/Medxy AIja2026-10-17T03:35:07-07:00駆出率が保たれた心不全における顕著なV波：右室後負荷および肺血管評価における役割 https://news.medxy.ai/vi/sv-in-heart-failure/Medxy AIvi2026-10-17T03:34:41-07:00Sóng V nổi bật trong suy tim phân suất tống máu bảo tồn: Vai trò đối với hậu gánh thất phải và đánh giá mạch máu phổi https://news.medxy.ai/prominent-v-waves-in-heart-failure-with-preserved-ejection-fraction-unveiling-their-impact-on-right-ventricular-afterload-and-pulmonary-vascular-assessment/Medxy AIen2026-10-17T03:34:19-07:00Prominent V Waves in Heart Failure with Preserved Ejection Fraction: Unveiling Their Impact on Right Ventricular Afterload and Pulmonary Vascular Assessment https://news.medxy.ai/zh/steps-intensity-mortality/Medxy AIzh2026-10-17T03:33:37-07:00步数与强度如何协同降低死亡风险：来自 UK Biobank 加速度计数据的启示 https://news.medxy.ai/ja/optimal-steps-intensity/Medxy AIja2026-10-17T03:33:16-07:00死亡リスクを下げる歩数と強度の最適化：UK Biobank加速度計データが示す知見 https://news.medxy.ai/vi/optimize-walking/Medxy AIvi2026-10-17T03:32:53-07:00Tối ưu số bước và cường độ đi bộ để giảm nguy cơ tử vong: Góc nhìn từ dữ liệu máy đo gia tốc của UK Biobank https://news.medxy.ai/optimizing-step-counts-and-intensity-to-reduce-mortality-risk-insights-from-uk-biobank-accelerometer-data/Medxy AIen2026-10-17T03:32:30-07:00Optimizing Step Counts and Intensity to Reduce Mortality Risk: Insights from UK Biobank Accelerometer Data https://news.medxy.ai/zh/social-integration-mortality/Medxy AIzh2026-10-17T03:31:50-07:00社会整合随时间变化对创伤性脊髓损伤后死亡率的影响：SCIMS纵向研究新发现 https://news.medxy.ai/ja/social-integration-spinal-injury/Medxy AIja2026-10-17T03:31:30-07:00外傷性脊髄損傷後の死亡リスクに対する時間変動する社会統合の影響：SCIMS縦断研究からの知見 https://news.medxy.ai/vi/social-integration-impact/Medxy AIvi2026-10-17T03:31:06-07:00Hòa nhập xã hội biến thiên theo thời gian ảnh hưởng thế nào đến tử vong sau chấn thương tủy sống do chấn thương: phát hiện từ nghiên cứu dọc SCIMS https://news.medxy.ai/impact-of-time-varying-social-integration-on-mortality-following-traumatic-spinal-cord-injury-insights-from-the-scims-longitudinal-study/Medxy AIen2026-10-17T03:30:44-07:00Impact of Time-Varying Social Integration on Mortality Following Traumatic Spinal Cord Injury: Insights from the SCIMS Longitudinal Study https://news.medxy.ai/zh/primary-cilium-cep164-role/Medxy AIzh2026-10-17T03:30:03-07:00揭示初级纤毛与CEP164过表达在釉质母细胞瘤发病机制中的作用 https://news.medxy.ai/ja/primary-cilium-cep164-enameloma/Medxy AIja2026-10-17T03:29:41-07:00一次繊毛とCEP164過剰発現がエナメル上皮腫の病態をどう形作るのか https://news.medxy.ai/vi/primary-cilia-cep164-tumor/Medxy AIvi2026-10-17T03:29:14-07:00Làm rõ vai trò của lông chuyển nguyên phát và biểu hiện quá mức CEP164 trong sinh học bệnh của u tạo men https://news.medxy.ai/unveiling-the-role-of-primary-cilia-and-cep164-overexpression-in-ameloblastoma-pathobiology/Medxy AIen2026-10-17T03:28:52-07:00Unveiling the Role of Primary Cilia and CEP164 Overexpression in Ameloblastoma Pathobiology https://news.medxy.ai/zh/survodutide-obesity-diabetes/Medxy AIzh2026-10-17T03:28:14-07:00每周一次 Survodutide 用于肥胖合并2型糖尿病成人：证据与临床启示的当代综述 https://news.medxy.ai/ja/weekly-survodutide-review/Medxy AIja2026-10-17T03:27:49-07:00肥満と2型糖尿病に対する週1回Survodutide：エビデンスと臨床的意義の最新レビュー https://news.medxy.ai/vi/survodutide-weekly-obesity-diabetes/Medxy AIvi2026-10-17T03:27:22-07:00Survodutide dùng hằng tuần ở người lớn mắc béo phì và đái tháo đường type 2: Tổng quan cập nhật về bằng chứng và ý nghĩa lâm sàng https://news.medxy.ai/survodutide-once-weekly-in-adults-with-obesity-and-type-2-diabetes-a-contemporary-review-of-evidence-and-clinical-implications/Medxy AIen2026-10-17T03:26:56-07:00Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes: A Contemporary Review of Evidence and Clinical Implications https://news.medxy.ai/zh/84895-2/Medxy AIzh2026-10-16T07:26:31-07:00“首尾一贯感”可能提升康复成效：一项为期3年的纵向研究的启示 https://news.medxy.ai/ja/consistent-sense-rehabilitation/Medxy AIja2026-10-16T07:26:17-07:00首尾一貫感覚がリハビリテーション成績を高める可能性：3年間縦断研究からの示唆 https://news.medxy.ai/vi/sense-of-coherence/Medxy AIvi2026-10-16T07:26:00-07:00Tăng cường kết quả phục hồi chức năng nhờ Sense of Coherence: Góc nhìn từ nghiên cứu theo dõi dọc 3 năm https://news.medxy.ai/enhancing-rehabilitation-outcomes-through-sense-of-coherence-insights-from-a-3-year-longitudinal-study/Medxy AIen2026-10-16T07:25:44-07:00Enhancing Rehabilitation Outcomes Through Sense of Coherence: Insights From a 3-Year Longitudinal Study https://news.medxy.ai/zh/digital-aid-periodontal-treatment/Medxy AIzh2026-10-16T07:25:12-07:00数字伴随应用用于牙周治疗的价值评估：来自多中心随机对照试验的启示 https://news.medxy.ai/ja/digital-companion-app/Medxy AIja2026-10-16T07:24:57-07:00歯周治療におけるデジタルコンパニオンアプリの影響を検証する：多施設ランダム化比較試験からの知見 https://news.medxy.ai/vi/digital-companion-therapy/Medxy AIvi2026-10-16T07:24:40-07:00Ứng dụng đồng hành kỹ thuật số trong điều trị nha chu: Kết quả từ một thử nghiệm ngẫu nhiên có đối chứng đa trung tâm https://news.medxy.ai/evaluating-the-impact-of-a-digital-companion-app-in-periodontal-therapy-insights-from-a-multi-center-randomised-controlled-trial/Medxy AIen2026-10-16T07:24:23-07:00Evaluating the Impact of a Digital Companion App in Periodontal Therapy: Insights from a Multi-Center Randomised Controlled Trial https://news.medxy.ai/zh/roam-eortc-trial/Medxy AIzh2026-10-16T07:23:50-07:00WHO 2级非典型脑膜瘤完全切除后辅助放射治疗可显著降低复发：ROAM/EORTC-1308 3期试验带来新证据 https://news.medxy.ai/ja/grade-2-meningioma-radiotherapy/Medxy AIja2026-10-16T07:23:35-07:00WHOグレード2異型髄膜腫の完全切除後補助放射線療法は再発を抑制する：ROAM/EORTC-1308第3相試験からの知見 https://news.medxy.ai/vi/adjuvant-radiotherapy-menigioma/Medxy AIvi2026-10-16T07:23:15-07:00Xạ trị bổ trợ giúp giảm tái phát sau cắt bỏ hoàn toàn u màng não không điển hình độ 2 theo WHO: Kết quả nổi bật từ thử nghiệm giai đoạn 3 ROAM/EORTC-1308 https://news.medxy.ai/adjuvant-radiotherapy-reduces-recurrence-after-complete-resection-of-who-grade-2-atypical-meningioma-insights-from-the-roam-eortc-1308-phase-3-trial/Medxy AIen2026-10-16T07:22:57-07:00Adjuvant Radiotherapy Reduces Recurrence After Complete Resection of WHO Grade 2 Atypical Meningioma: Insights from the ROAM/EORTC-1308 Phase 3 Trial https://news.medxy.ai/an-infant-with-extreme-hypernatremia-treated-with-peritoneal-dialysis/Medxy AIen2026-10-16T07:22:22-07:00An Infant With Extreme Hypernatremia Treated With Peritoneal Dialysis https://news.medxy.ai/ja/lupus-nephritis-care/Medxy AIja2026-10-16T07:21:47-07:00ループス腎炎ケアの質指標：2025年EULAR推奨を実装するために――作成、遵守状況、転帰への影響 https://news.medxy.ai/vi/lupus-nephritis-markers/Medxy AIvi2026-10-16T07:21:23-07:00Viêm thận lupus: bộ chỉ số chất lượng mới theo khuyến cáo EULAR 2025 và ý nghĩa đối với kết cục điều trị https://news.medxy.ai/zh/lupus-nephritis-care-2/Medxy AIzh2026-10-16T07:20:58-07:00狼疮性肾炎护理质量指标：2025年EULAR建议的实施、依从性及其对结局的影响 https://news.medxy.ai/lupus-nephritis-quality/Medxy AIen2026-10-16T07:20:33-07:00Quality indicators for lupus nephritis care: implementing the 2025 EULAR recommendations — development, adherence, and impact on outcomes https://news.medxy.ai/zh/lung-transplant-dysfunction/Medxy AIzh2026-10-16T07:19:33-07:00双肺移植后的基线肺移植物功能障碍：影响因素与长期肺功能结局 https://news.medxy.ai/ja/lung-transplant-issues/Medxy AIja2026-10-16T07:19:18-07:00両肺移植後のベースライン肺同種移植片機能障害：規定因子と長期肺転帰 https://news.medxy.ai/vi/lung-transplant-dysfunction-2/Medxy AIvi2026-10-16T07:19:00-07:00Suy chức năng mảnh ghép phổi nền sau ghép phổi hai bên: yếu tố quyết định và kết cục hô hấp dài hạn https://news.medxy.ai/baseline-lung-allograft-dysfunction-after-bilateral-lung-transplantation-determinants-and-long-term-pulmonary-outcomes/Medxy AIen2026-10-16T07:18:42-07:00Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation: Determinants and Long-Term Pulmonary Outcomes https://news.medxy.ai/zh/sonelokimab-hidradenitis-treatment/Medxy AIzh2026-10-16T07:18:07-07:00Sonelokimab：面向中重度化脓性汗腺炎的双靶点 IL-17A/F 纳米抗体新希望 https://news.medxy.ai/ja/sonelokimab-treatment/Medxy AIja2026-10-16T07:17:52-07:00化膿性汗腺炎に挑む新規治療：SonelokimabのIL-17A/F二重標的作用に期待 https://news.medxy.ai/vi/sonelokimab-il17af/Medxy AIvi2026-10-16T07:17:36-07:00Sonelokimab: Nanobody kép IL-17A/F đầy hứa hẹn cho hidradenitis suppurativa mức độ vừa đến nặng https://news.medxy.ai/sonelokimab-a-promising-dual-il-17a-f-nanobody-for-moderate-to-severe-hidradenitis-suppurativa/Medxy AIen2026-10-16T07:17:21-07:00Sonelokimab: A Promising Dual IL-17A/F Nanobody for Moderate-to-Severe Hidradenitis Suppurativa https://news.medxy.ai/zh/cleft-lip-repair/Medxy AIzh2026-10-16T07:16:44-07:00微型唇裂修复的长期对称性与美学优势：19年鼻唇肌张力线重建经验 https://news.medxy.ai/ja/84853-2/Medxy AIja2026-10-16T07:16:30-07:00微小口唇裂修復における長期的な対称性と審美的優位性：鼻唇筋張力線再建の19年にわたる経験 https://news.medxy.ai/vi/cleft-lip-repair-2/Medxy AIvi2026-10-16T07:16:11-07:00Sửa chữa khe hở môi thể vi dạng với kết quả đối xứng bền vững: Góc nhìn từ 19 năm tái tạo đường lực căng cơ mũi–môi https://news.medxy.ai/sustained-symmetry-and-aesthetic-excellence-in-microform-cleft-lip-repair-insights-from-19-years-of-nasolabial-muscle-tension-line-reconstruction/Medxy AIen2026-10-16T07:15:53-07:00Sustained Symmetry and Aesthetic Excellence in Microform Cleft Lip Repair: Insights from 19 Years of Nasolabial Muscle Tension Line Reconstruction https://news.medxy.ai/zh/bd-maintenance-treatment/Medxy AIzh2026-10-16T07:15:19-07:00首次精神病性躁狂后如何优化维持治疗？来自 BD-CAUSAL Collaboration 的研究启示 https://news.medxy.ai/ja/84840-2/Medxy AIja2026-10-16T07:15:03-07:00初回精神病性躁病後の維持療法を最適化するには？BD-CAUSAL Collaborationによる研究からの示唆 https://news.medxy.ai/vi/maintenance-treatment-optimization/Medxy AIvi2026-10-16T07:14:45-07:00Tối ưu hóa điều trị duy trì sau đợt hưng cảm loạn thần đầu tiên: Bằng chứng từ hợp tác BD-CAUSAL https://news.medxy.ai/optimizing-maintenance-therapy-after-first-episode-psychotic-mania-insights-from-the-bd-causal-collaboration/Medxy AIen2026-10-16T07:14:28-07:00Optimizing Maintenance Therapy After First Episode Psychotic Mania: Insights from the BD-CAUSAL Collaboration https://news.medxy.ai/zh/diabetes-atherosclerosis-prognosis/Medxy AIzh2026-10-16T07:13:55-07:00糖尿病与动脉粥样硬化性心血管疾病如何影响sTNFR1在脓毒症死亡中的预后价值 https://news.medxy.ai/ja/stnfr1-prognosis-sepsis/Medxy AIja2026-10-16T07:13:38-07:00敗血症死亡におけるsTNFR1の予後的意義は糖尿病とASCVDでどう変わるか https://news.medxy.ai/vi/84830-2/Medxy AIvi2026-10-16T07:13:18-07:00Ảnh hưởng của bệnh đái tháo đường và bệnh tim mạch do xơ vữa động mạch đến vai trò tiên lượng của sTNFR1 đối với tỷ lệ tử vong do nhiễm khuẩn huyết https://news.medxy.ai/impact-of-diabetes-and-atherosclerotic-cardiovascular-disease-on-the-prognostic-role-of-stnfr1-in-sepsis-mortality/Medxy AIen2026-10-16T07:13:01-07:00Impact of Diabetes and Atherosclerotic Cardiovascular Disease on the Prognostic Role of sTNFR1 in Sepsis Mortality https://news.medxy.ai/supporting-patients-with-autism-spectrum-disorder-and-neurodivergence-in-serious-illness-decision-making/Medxy AIen2026-10-16T07:12:27-07:00Supporting Patients with Autism Spectrum Disorder and Neurodivergence in Serious Illness Decision-Making https://news.medxy.ai/zh/multiple-myeloma-microenvironment/Medxy AIzh2026-10-16T07:11:56-07:00绘制多发性骨髓瘤肿瘤微环境图谱：基于疾病不同阶段单细胞分析的启示 https://news.medxy.ai/ja/tumor-microenvironment-map/Medxy AIja2026-10-16T07:11:38-07:00多発性骨髄腫における腫瘍微小環境の地図化：病期横断的な単一細胞解析から得られた知見 https://news.medxy.ai/vi/tumor-microenvironment-map-2/Medxy AIvi2026-10-16T07:11:20-07:00Bản đồ vi môi trường khối u trong đa u tủy: những phát hiện từ phân tích đơn bào qua các giai đoạn bệnh https://news.medxy.ai/mapping-the-tumor-microenvironment-in-multiple-myeloma-insights-from-single-cell-analysis-across-disease-stages/Medxy AIen2026-10-16T07:10:59-07:00Mapping the Tumor Microenvironment in Multiple Myeloma: Insights from Single-Cell Analysis Across Disease Stages https://news.medxy.ai/zh/foxf1-pah-mechanism/Medxy AIzh2026-10-16T07:10:23-07:00FOXF1 变异与肺动脉高压发病机制：从遗传易感到 BMPR2 调控 https://news.medxy.ai/ja/foxf1-pulmonary-hypertension/Medxy AIja2026-10-16T07:10:09-07:00肺動脈性肺高血圧症の病態におけるFOXF1変異の役割を解明 https://news.medxy.ai/vi/foxf1-variants-role/Medxy AIvi2026-10-16T07:09:54-07:00Vai trò của các biến thể FOXF1 trong sinh bệnh học tăng áp động mạch phổi https://news.medxy.ai/unveiling-the-role-of-foxf1-variants-in-pulmonary-arterial-hypertension-pathogenesis/Medxy AIen2026-10-16T07:09:39-07:00Unveiling the Role of FOXF1 Variants in Pulmonary Arterial Hypertension Pathogenesis https://news.medxy.ai/zh/84800-2/Medxy AIzh2026-10-16T07:09:09-07:00西班牙裔/拉丁裔成人糖尿病视网膜病变与心血管风险因素的患病率：来自 HCHS/SOL 和 SOL Ojos 研究的发现 https://news.medxy.ai/ja/diabetic-retinopathy-prevalence/Medxy AIja2026-10-16T07:08:49-07:00ヒスパニック／ラテン系成人における糖尿病網膜症と心血管リスク因子の有病率：HCHS/SOL と SOL Ojos 研究からの知見 https://news.medxy.ai/vi/diabetic-retinopathy-burden/Medxy AIvi2026-10-16T07:08:30-07:00Gánh nặng bệnh võng mạc đái tháo đường và các yếu tố nguy cơ tim mạch ở người trưởng thành Hispanic/Latino đa dạng: Kết quả từ HCHS/SOL và SOL Ojos https://news.medxy.ai/prevalence-of-diabetic-retinopathy-and-cardiovascular-risk-factors-among-diverse-hispanic-latino-adults-insights-from-the-hchs-sol-and-sol-ojos-studies/Medxy AIen2026-10-16T07:08:10-07:00Prevalence of Diabetic Retinopathy and Cardiovascular Risk Factors Among Diverse Hispanic/Latino Adults: Insights from the HCHS/SOL and SOL Ojos Studies https://news.medxy.ai/zh/parotid-surgery-nerve-visibility/Medxy AIzh2026-10-16T07:07:24-07:00腮腺手术中面神经更清晰可见：FIESTA-C 联合 MENSA MRI 的价值 https://news.medxy.ai/ja/fieasta-mri-benefits/Medxy AIja2026-10-16T07:07:09-07:00耳下腺手術における顔面神経描出を高めるFIESTA-C＋MENSA併用MRIの有用性 https://news.medxy.ai/vi/facial-nerve-mri-guidance/Medxy AIvi2026-10-16T07:06:52-07:00Nâng cao khả năng quan sát dây thần kinh mặt bằng phối hợp chuỗi MRI FIESTA-C và MENSA trong phẫu thuật tuyến mang tai https://news.medxy.ai/enhanced-visualization-of-facial-nerve-using-combined-fiesta-c-and-mensa-mri-sequences-in-parotid-gland-surgery/Medxy AIen2026-10-16T07:06:33-07:00Enhanced Visualization of Facial Nerve Using Combined FIESTA-C and MENSA MRI Sequences in Parotid Gland Surgery https://news.medxy.ai/zh/fda-surgical-ai/Medxy AIzh2026-10-16T07:05:58-07:00FDA 批准外科 AI 器械全景：创新进展、证据基础与监管挑战 https://news.medxy.ai/ja/fda-approved-surgical-ai/Medxy AIja2026-10-16T07:05:41-07:00FDA承認外科用AI機器を読み解く：技術革新、エビデンス、規制上の課題 https://news.medxy.ai/vi/ai-surgery-devices-map/Medxy AIvi2026-10-16T07:05:23-07:00Bản đồ các thiết bị AI trong phẫu thuật được FDA phê duyệt: Đổi mới, bằng chứng và thách thức quản lý https://news.medxy.ai/navigating-the-landscape-of-fda-approved-surgical-ai-devices-innovation-evidence-and-regulatory-challenges/Medxy AIen2026-10-16T07:05:06-07:00Navigating the Landscape of FDA-Approved Surgical AI Devices: Innovation, Evidence, and Regulatory Challenges https://news.medxy.ai/zh/tubal-sterilization-consent/Medxy AIzh2026-10-16T07:04:26-07:00提升输卵管绝育知情同意质量：患者教育网站的作用 https://news.medxy.ai/ja/tubal-ligation-consent/Medxy AIja2026-10-16T07:04:09-07:00卵管滅菌術のインフォームド・コンセントを高めるには：患者中心教育ウェブサイトの効果 https://news.medxy.ai/vi/improving-consent-quality/Medxy AIvi2026-10-16T07:03:50-07:00Nâng cao chất lượng đồng ý sau khi được thông tin trong triệt sản vòi trứng: tác động của một website giáo dục lấy người bệnh làm trung tâm https://news.medxy.ai/enhancing-informed-consents-in-tubal-sterilization-impact-of-a-patient-centered-educational-website/Medxy AIen2026-10-16T07:03:33-07:00Enhancing Informed Consents in Tubal Sterilization: Impact of a Patient-Centered Educational Website https://news.medxy.ai/zh/zfp36l1-liver-aging/Medxy AIzh2026-10-16T07:02:59-07:00依赖锌的 RNA 结合蛋白 ZFP36L1：调控肝细胞衰老与酒精相关性肝病恢复的关键因子 https://news.medxy.ai/ja/zfp36l1-liver-aging-3/Medxy AIja2026-10-16T07:02:42-07:00亜鉛依存性RNA結合タンパク質ZFP36L1：肝細胞老化とアルコール関連肝疾患回復を制御する重要因子 https://news.medxy.ai/vi/zfp36l1-liver-aging-2/Medxy AIvi2026-10-16T07:02:24-07:00ZFP36L1 – protein gắn RNA phụ thuộc kẽm: ‘chốt chặn’ quan trọng trong lão hóa tế bào gan và hồi phục bệnh gan do rượu https://news.medxy.ai/zinc-dependent-rna-binding-protein-zfp36l1-a-key-regulator-of-hepatocyte-senescence-and-alcohol-related-liver-disease-recovery/Medxy AIen2026-10-16T07:02:04-07:00Zinc-Dependent RNA Binding Protein ZFP36L1: A Key Regulator of Hepatocyte Senescence and Alcohol-Related Liver Disease Recovery https://news.medxy.ai/zh/hematoma-location-impact/Medxy AIzh2026-10-16T07:01:32-07:00血肿部位：急性脑内出血强化降压疗效的关键影响因素 https://news.medxy.ai/ja/84749-2/Medxy AIja2026-10-16T07:01:13-07:00血腫部位：急性脳内出血における強化降圧療法の効果を左右する重要な因子 https://news.medxy.ai/vi/hematoma-location/Medxy AIvi2026-10-16T07:00:55-07:00Vị trí khối máu tụ: yếu tố then chốt quyết định hiệu quả hạ huyết áp tích cực trong xuất huyết não cấp https://news.medxy.ai/hematoma-location-as-a-key-modifier-of-intensive-blood-pressure-lowering-outcomes-in-acute-intracerebral-hemorrhage/Medxy AIen2026-10-16T07:00:38-07:00Hematoma Location as a Key Modifier of Intensive Blood Pressure Lowering Outcomes in Acute Intracerebral Hemorrhage https://news.medxy.ai/zh/twiist-insulin-therapy/Medxy AIzh2026-10-16T06:59:59-07:00twiist 自动化胰岛素输注系统在接受胰岛素治疗的 2 型糖尿病中的疗效与安全性：twiist-T2D 关键性试验及相关证据综述 https://news.medxy.ai/ja/twiist-insulin-efficacy/Medxy AIja2026-10-16T06:59:39-07:00インスリン治療中2型糖尿病におけるtwiist自動インスリン送達システムの有効性と安全性：twiist-T2D主要試験と関連エビデンスの包括的レビュー https://news.medxy.ai/vi/84743-2/Medxy AIvi2026-10-16T06:59:21-07:00Hiệu quả và độ an toàn của hệ thống phân phối insulin tự động twiist ở bệnh nhân đái tháo đường tuýp 2 đang điều trị bằng insulin: Thử nghiệm then chốt twiist-T2D và tổng quan các bằng chứng liên quan https://news.medxy.ai/efficacy-and-safety-of-the-twiist-automated-insulin-delivery-system-in-insulin-treated-type-2-diabetes-a-comprehensive-review-of-the-twiist-t2d-pivotal-trial-and-related-evidence/Medxy AIen2026-10-16T06:59:03-07:00Efficacy and Safety of the twiist Automated Insulin Delivery System in Insulin-Treated Type 2 Diabetes: A Comprehensive Review of the twiist-T2D Pivotal Trial and Related Evidence https://news.medxy.ai/zh/palmitic-acid-heart-failure/Medxy AIzh2026-10-16T06:58:09-07:00棕榈酸与心脏肥大：揭示驱动心力衰竭的表观遗传记忆 https://news.medxy.ai/ja/palmitic-acid-heart-failure-3/Medxy AIja2026-10-16T06:57:53-07:00パルミチン酸と心肥大：心不全を駆動するエピジェネティック記憶の解明 https://news.medxy.ai/vi/palmitic-acid-heart-failure-2/Medxy AIvi2026-10-16T06:57:36-07:00Axit palmitic và phì đại tim: Giải mã ‘ký ức’ biểu sinh thúc đẩy suy tim https://news.medxy.ai/palmitic-acid-and-cardiac-hypertrophy-unveiling-the-epigenetic-memory-driving-heart-failure/Medxy AIen2026-10-16T06:57:18-07:00Palmitic Acid and Cardiac Hypertrophy: Unveiling the Epigenetic Memory Driving Heart Failure https://news.medxy.ai/zh/84734-2/Medxy AIzh2026-10-16T06:56:39-07:00OBVAM 对脑震荡相关集合功能不全伴随​​的调节功能障碍是否有效：CONCUSS 随机临床试验的发现 https://news.medxy.ai/ja/obvam-concuss-trial/Medxy AIja2026-10-16T06:56:20-07:00脳震盪関連輻輳不全に伴う調節機能障害へOBVAMは有効か：CONCUSS無作為化臨床試験の知見 https://news.medxy.ai/vi/concussion-therapy-effectiveness/Medxy AIvi2026-10-16T06:55:59-07:00Hiệu quả của liệu pháp dung hợp điều tiết/hội tụ tại phòng khám có vận động đối với rối loạn điều tiết trong thiếu hội tụ liên quan đến chấn động não: Góc nhìn từ thử nghiệm lâm sàng ngẫu nhiên CONCUSS https://news.medxy.ai/effectiveness-of-office-based-vergence-accommodative-therapy-with-movement-for-accommodative-dysfunction-in-concussion-related-convergence-insufficiency-insights-from-the-concuss-randomised-clinical/Medxy AIen2026-10-16T06:55:38-07:00Effectiveness of Office-Based Vergence/Accommodative Therapy with Movement for Accommodative Dysfunction in Concussion-Related Convergence Insufficiency: Insights from the CONCUSS Randomised Clinical Trial https://news.medxy.ai/zh/laser-vs-shockwave-treatment-2/Medxy AIzh2026-10-16T06:54:52-07:00高强度激光治疗与体外冲击波治疗在烧伤后肘管综合征中的比较疗效：一项随机对照试验 https://news.medxy.ai/ja/laser-vs-shockwave-treatment/Medxy AIja2026-10-16T06:54:31-07:00熱傷後肘部管症候群に対する高強度レーザー治療と衝撃波治療の有効性比較：ランダム化比較試験 https://news.medxy.ai/vi/84720-2/Medxy AIvi2026-10-16T06:54:11-07:00So sánh hiệu quả của liệu pháp laser cường độ cao và liệu pháp sóng xung kích ngoài cơ thể trong điều trị hội chứng ống khuỷu sau bỏng https://news.medxy.ai/comparative-effectiveness-of-high-intensity-laser-therapy-versus-shock-wave-therapy-in-post-burn-cubital-tunnel-syndrome-a-randomized-controlled-trial/Medxy AIen2026-10-16T06:53:53-07:00Comparative Effectiveness of High-Intensity Laser Therapy Versus Shock Wave Therapy in Post-Burn Cubital Tunnel Syndrome: A Randomized Controlled Trial https://news.medxy.ai/zh/deep-learning-jaw-lesions/Medxy AIzh2026-10-16T06:53:19-07:00深度学习助力颌骨纤维-骨性病变的精准鉴别 https://news.medxy.ai/ja/fibrous-bone-lesion-ai/Medxy AIja2026-10-16T06:53:03-07:00顎骨線維性・骨性病変の正確な鑑別へ向けた深層学習の活用 https://news.medxy.ai/vi/deep-learning-bone-lesions/Medxy AIvi2026-10-16T06:52:48-07:00Tăng cường deep learning để phân biệt chính xác các tổn thương xơ–xương của hàm https://news.medxy.ai/harnessing-deep-learning-for-accurate-differentiation-of-fibro-osseous-jaw-lesions/Medxy AIen2026-10-16T06:52:30-07:00Harnessing Deep Learning for Accurate Differentiation of Fibro-Osseous Jaw Lesions https://news.medxy.ai/zh/septic-shock-resuscitation-2/Medxy AIzh2026-10-16T06:51:56-07:00脓毒性休克早期复苏如何优化：液体与血管加压药的平衡 https://news.medxy.ai/ja/septic-shock-resuscitation/Medxy AIja2026-10-16T06:51:37-07:00敗血症性ショック初期蘇生の最適化：輸液と昇圧薬のバランスを考える https://news.medxy.ai/vi/sepsis-fluid-therapy/Medxy AIvi2026-10-16T06:51:19-07:00Sốc nhiễm khuẩn giai đoạn sớm: cân bằng giữa dịch truyền và thuốc vận mạch để tối ưu hồi sức ban đầu https://news.medxy.ai/optimizing-early-resuscitation-in-septic-shock-balancing-fluids-and-vasopressors/Medxy AIen2026-10-16T06:51:01-07:00Optimizing Early Resuscitation in Septic Shock: Balancing Fluids and Vasopressors https://news.medxy.ai/zh/tasit-validation/Medxy AIzh2026-10-15T12:30:16-07:00创伤性脑损伤后社会认知评估提效：挪威语简版TASIT的信度与效度验证 https://news.medxy.ai/ja/tbi-social-cognition/Medxy AIja2026-10-15T12:30:00-07:00TBI後の社会認知評価を効率化：ノルウェー語版TASIT短縮版の妥当性と信頼性 https://news.medxy.ai/vi/social-cognition-assessment/Medxy AIvi2026-10-15T12:29:42-07:00Tinh gọn đánh giá nhận thức xã hội sau chấn thương sọ não: độ hợp lệ và độ tin cậy của phiên bản ngắn tiếng Na Uy của TASIT https://news.medxy.ai/streamlining-social-cognition-assessment-post-traumatic-brain-injury-validity-and-reliability-of-the-norwegian-short-awareness-of-social-inference-test/Medxy AIen2026-10-15T12:29:24-07:00Streamlining Social Cognition Assessment Post-Traumatic Brain Injury: Validity and Reliability of the Norwegian Short-Awareness of Social Inference Test https://news.medxy.ai/zh/palate-wound-closure/Medxy AIzh2026-10-15T12:28:45-07:00腭部创面闭合哪种更优？PRF、PRGF、胶原替代材料与自然愈合的随机对照研究 https://news.medxy.ai/ja/84604-2/Medxy AIja2026-10-15T12:28:25-07:00口蓋部創面の閉鎖において、PRF、PRGF、コラーゲン代替材料、および自然治癒のいずれが優れているか？：ランダム化比較試験 https://news.medxy.ai/vi/prf-prgf-collagen-wound-healing/Medxy AIvi2026-10-15T12:28:04-07:00So sánh hiệu quả của PRF, PRGF, vật liệu thay thế collagen và liền thương tự phát trong đóng vết thương khẩu cái: Góc nhìn từ một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/comparative-efficacy-of-prf-prgf-collagen-substitute-and-spontaneous-healing-in-palatal-wound-closure-insights-from-a-randomised-controlled-trial/Medxy AIen2026-10-15T12:27:43-07:00Comparative Efficacy of PRF, PRGF, Collagen Substitute, and Spontaneous Healing in Palatal Wound Closure: Insights from a Randomised Controlled Trial https://news.medxy.ai/zh/retatrutide-triple-agonist/Medxy AIzh2026-10-15T12:27:04-07:00Retatrutide：肥胖与 2 型糖尿病管理的新突破性三重激动剂 https://news.medxy.ai/ja/retatrutide-obesity-diabetes/Medxy AIja2026-10-15T12:26:47-07:00Retatrutide、肥満・2型糖尿病治療に挑む三重作動薬の新展開 https://news.medxy.ai/vi/retatrutide-treatment/Medxy AIvi2026-10-15T12:26:26-07:00Retatrutide: Chất chủ vận ba đích đầy triển vọng trong điều trị béo phì và đái tháo đường type 2 https://news.medxy.ai/retatrutide-a-breakthrough-triple-agonist-for-obesity-and-type-2-diabetes-management/Medxy AIen2026-10-15T12:26:08-07:00Retatrutide: A Breakthrough Triple Agonist for Obesity and Type 2 Diabetes Management https://news.medxy.ai/zh/therapeutic-riding-autism/Medxy AIzh2026-10-15T12:25:26-07:00治疗性骑马：改善孤独症青少年行为问题的潜在干预 https://news.medxy.ai/ja/therapeutic-riding-autism-2/Medxy AIja2026-10-15T12:25:08-07:00自閉スペクトラム症の若年者における治療的乗馬：行動面の課題に対する有望な介入 https://news.medxy.ai/vi/therapeutic-horseback-riding/Medxy AIvi2026-10-15T12:24:46-07:00Đạp ngựa trị liệu: Can thiệp đầy hứa hẹn cho các khó khăn hành vi ở trẻ vị thành niên mắc tự kỷ và bệnh đồng mắc tâm thần https://news.medxy.ai/therapeutic-horseback-riding-a-promising-intervention-for-behavioral-challenges-in-youth-with-autism-and-psychiatric-comorbidities/Medxy AIen2026-10-15T12:24:27-07:00Therapeutic Horseback Riding: A Promising Intervention for Behavioral Challenges in Youth with Autism and Psychiatric Comorbidities https://news.medxy.ai/zh/igg4-disease-cancer-risk/Medxy AIzh2026-10-15T12:23:41-07:00大型队列研究显示：IgG4相关疾病并未增加恶性肿瘤风险 https://news.medxy.ai/ja/igg4-disease-no-cancer-risk/Medxy AIja2026-10-15T12:23:24-07:00IgG4関連疾患、悪性腫瘍リスク上昇なし　大規模コホート研究が示した新知見 https://news.medxy.ai/vi/igg4-related-diseases/Medxy AIvi2026-10-15T12:23:04-07:00Bệnh liên quan đến IgG4 không làm tăng nguy cơ ác tính: Góc nhìn từ một nghiên cứu đoàn hệ quy mô lớn https://news.medxy.ai/igg4-related-disease-shows-no-increased-risk-of-malignancy-insights-from-a-large-cohort-study/Medxy AIen2026-10-15T12:22:46-07:00IgG4-Related Disease Shows No Increased Risk of Malignancy: Insights from a Large Cohort Study https://news.medxy.ai/zh/food-access-nahcc-metabolic-dysfunction-fatty-liver/Medxy AIzh2026-10-15T12:22:03-07:00食物可及性不足如何影响肝移植候选者的代谢功能障碍相关脂肪性肝病与衰弱：一项地理空间分析 https://news.medxy.ai/ja/84584-2/Medxy AIja2026-10-15T12:21:45-07:00食料へのアクセスの不足が、肝移植候補者における代謝機能障害関連脂肪性肝疾患およびフレイルに及ぼす影響 https://news.medxy.ai/vi/food-access-liver-failure/Medxy AIvi2026-10-15T12:21:23-07:00Khả năng tiếp cận thực phẩm kém ảnh hưởng ra sao đến bệnh gan chuyển hóa và tình trạng suy kiệt ở ứng viên ghép gan? Phân tích không gian địa lý https://news.medxy.ai/impact-of-poor-food-access-on-metabolic-dysfunction-associated-liver-disease-and-frailty-among-liver-transplant-candidates-a-geospatial-analysis/Medxy AIen2026-10-15T12:21:01-07:00Impact of Poor Food Access on Metabolic Dysfunction-associated Liver Disease and Frailty Among Liver Transplant Candidates: A Geospatial Analysis https://news.medxy.ai/acquired-hair-texture-alteration-after-regrowth-in-alopecia-areata-a-distinct-clinical-and-ultrastructural-phenotype/Medxy AIen2026-10-15T12:20:11-07:00Acquired Hair Texture Alteration After Regrowth in Alopecia Areata: A Distinct Clinical and Ultrastructural Phenotype https://news.medxy.ai/zh/reduce-hump-recurrence/Medxy AIzh2026-10-15T12:19:33-07:00优化固定技术，降低低鼻中隔条带保留性鼻整形术后的驼峰复发 https://news.medxy.ai/ja/84577-2/Medxy AIja2026-10-15T12:19:16-07:00固定技術の最適化による、鼻中隔軟​​骨ストリップ温存型鼻形成術後のハンプ再発の低減 https://news.medxy.ai/vi/nose-augmentation-optimization/Medxy AIvi2026-10-15T12:19:00-07:00Tối ưu kỹ thuật cố định để ngăn tái phát gồ mũi trong nâng mũi bảo tồn bằng low septal strip https://news.medxy.ai/optimizing-fixation-techniques-to-prevent-hump-recurrence-in-low-strip-preservation-rhinoplasty/Medxy AIen2026-10-15T12:18:43-07:00Optimizing Fixation Techniques to Prevent Hump Recurrence in Low Strip Preservation Rhinoplasty https://news.medxy.ai/zh/84573-2/Medxy AIzh2026-10-15T12:18:04-07:00美国在心理健康与物质使用障碍方面的支出：成本分析及对政策与护理优化的启示 https://news.medxy.ai/ja/84572-2/Medxy AIja2026-10-15T12:17:46-07:00米国におけるメンタルヘルスおよび物質使用障害への支出：費用分析と政策・ケアの最適化への示唆 https://news.medxy.ai/vi/mental-health-costs-us/Medxy AIvi2026-10-15T12:17:23-07:00Chi tiêu cho sức khỏe tâm thần và rối loạn sử dụng chất tại Hoa Kỳ: phân tích chi phí và hàm ý đối với chính sách, tối ưu hóa chăm sóc https://news.medxy.ai/mental-health-and-substance-use-disorder-expenditures-in-the-us-profiling-costs-and-implications-for-policy-and-care-optimization/Medxy AIen2026-10-15T12:17:01-07:00Mental Health and Substance Use Disorder Expenditures in the US: Profiling Costs and Implications for Policy and Care Optimization https://news.medxy.ai/zh/patient-dignity-scale/Medxy AIzh2026-10-15T12:16:05-07:00验证患者尊严量表：助力急性呼吸衰竭幸存者康复的新证据 https://news.medxy.ai/ja/patient-dignity-validation/Medxy AIja2026-10-15T12:15:48-07:00急性呼吸不全生存者の回復を支えるPatient Dignity Inventoryの妥当性検証 https://news.medxy.ai/vi/patient-dignity-index/Medxy AIvi2026-10-15T12:15:27-07:00Xác thực Chỉ số Phẩm giá Người bệnh để hỗ trợ phục hồi ở người sống sót sau suy hô hấp cấp https://news.medxy.ai/validating-the-patient-dignity-inventory-to-enhance-recovery-in-acute-respiratory-failure-survivors/Medxy AIen2026-10-15T12:15:08-07:00Validating the Patient Dignity Inventory to Enhance Recovery in Acute Respiratory Failure Survivors https://news.medxy.ai/zh/medical-interpreters-ai/Medxy AIzh2026-10-15T12:14:26-07:00医学口译员如何助力医疗韧性：AI 融入面临的机遇与挑战 https://news.medxy.ai/ja/84562-2/Medxy AIja2026-10-15T12:14:09-07:00医療通訳者は医療のレジリエンスにどう貢献するのか――AI導入に伴う機会と課題 https://news.medxy.ai/vi/medical-interpreter-role/Medxy AIvi2026-10-15T12:13:49-07:00Vai trò của thông dịch viên y khoa trong tăng cường khả năng chống chịu và những thách thức khi tích hợp trí tuệ nhân tạo https://news.medxy.ai/the-role-of-medical-interpreters-in-enhancing-resilience-and-the-challenges-for-artificial-intelligence-integration/Medxy AIen2026-10-15T12:13:30-07:00The Role of Medical Interpreters in Enhancing Resilience and the Challenges for Artificial Intelligence Integration https://news.medxy.ai/zh/hemophilia-diagnosis/Medxy AIzh2026-10-15T12:12:38-07:00血友病携带者与女性患者的识别与诊断：全面临床策略 https://news.medxy.ai/ja/hemophilia-diagnosis-3/Medxy AIja2026-10-15T12:12:23-07:00血友病保因者と女性患者の診断・評価をどう進めるか：包括的な臨床アプローチ https://news.medxy.ai/vi/hemophilia-diagnosis-2/Medxy AIvi2026-10-15T12:12:06-07:00Nhận diện và chẩn đoán người mang gen hemophilia cùng phụ nữ mắc bệnh: tiếp cận lâm sàng toàn diện https://news.medxy.ai/identifying-and-diagnosing-carriers-and-females-with-hemophilia-a-comprehensive-clinical-approach/Medxy AIen2026-10-15T12:11:48-07:00Identifying and Diagnosing Carriers and Females with Hemophilia: A Comprehensive Clinical Approach https://news.medxy.ai/ja/gina-2026-strategy-summary/Medxy AIja2026-10-15T12:11:11-07:00GINA 2026戦略レポート要点：エグゼクティブサマリーと主な改訂点 https://news.medxy.ai/vi/gina-strategy-2026/Medxy AIvi2026-10-15T12:10:41-07:00Báo cáo Chiến lược GINA 2026: Tóm tắt điều hành và những thay đổi then chốt https://news.medxy.ai/zh/84551-2/Medxy AIzh2026-10-15T12:10:11-07:00GINA 2026 战略报告：执行摘要与关键变更 https://news.medxy.ai/2026-global-initiative-for-asthma-gina-strategy-report-executive-summary-and-key-changes/Medxy AIen2026-10-15T12:09:44-07:002026 Global Initiative for Asthma (GINA) Strategy Report: Executive Summary and Key Changes https://news.medxy.ai/zh/diabetes-impact-dmek/Medxy AIzh2026-10-15T12:08:37-07:00供体糖尿病严重程度会影响DMEK术后1年结局吗？——来自糖尿病内皮角膜移植研究的证据 https://news.medxy.ai/ja/donor-diabetes-severity/Medxy AIja2026-10-15T12:08:18-07:00ドナー糖尿病重症度はDMEK後1年成績に影響するのか：Diabetes Endothelial Keratoplasty Studyからの知見 https://news.medxy.ai/vi/diabetes-impact-dmek-2/Medxy AIvi2026-10-15T12:07:57-07:00Mức độ nặng của đái tháo đường ở người hiến giác mạc có ảnh hưởng thế nào đến kết cục 1 năm sau DMEK? Phân tích từ Nghiên cứu Ghép nội mô giác mạc ở người hiến có đái tháo đường https://news.medxy.ai/impact-of-donor-diabetes-severity-on-1-year-outcomes-after-descemet-membrane-endothelial-keratoplasty-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIen2026-10-15T12:07:36-07:00Impact of Donor Diabetes Severity on 1-Year Outcomes After Descemet Membrane Endothelial Keratoplasty: Insights from the Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/zh/transoral-laser-throat-surgery/Medxy AIzh2026-10-15T12:06:52-07:00提升喉癌手术精准度：经口激光声带切除术中的离体共聚焦切缘评估 https://news.medxy.ai/ja/cordectomy-accuracy/Medxy AIja2026-10-15T12:06:33-07:00声門癌手術の精度向上：経口的レーザー cordectomy における ex vivo 共焦点断端評価 https://news.medxy.ai/vi/laryngectomy-laser-accuracy/Medxy AIvi2026-10-15T12:06:12-07:00Nâng cao độ chính xác phẫu thuật: Đánh giá bờ cắt ex vivo bằng kính hiển vi đồng tiêu trong cắt thanh quản bằng laser qua đường miệng cho ung thư thanh môn https://news.medxy.ai/advancing-surgical-precision-confocal-ex-vivo-margin-assessment-in-transoral-laser-cordectomy-for-glottic-cancer/Medxy AIen2026-10-15T12:05:54-07:00Advancing Surgical Precision: Confocal Ex Vivo Margin Assessment in Transoral Laser Cordectomy for Glottic Cancer https://news.medxy.ai/zh/post-colon-cancer-crp/Medxy AIzh2026-10-15T12:05:14-07:00结肠癌术后第2天CRP：及早识别低吻合口漏风险的实用指标 https://news.medxy.ai/ja/early-crp-detection/Medxy AIja2026-10-15T12:04:57-07:00結腸癌手術後の術後2日目CRPで探る、吻合部漏出低リスクの早期判定 https://news.medxy.ai/vi/early-detection-anastomotic-leak/Medxy AIvi2026-10-15T12:04:38-07:00Phát hiện sớm nguy cơ rò miệng nối thấp bằng CRP ngày hậu phẫu thứ 2 sau phẫu thuật ung thư đại tràng https://news.medxy.ai/early-identification-of-low-anastomotic-leakage-risk-using-postoperative-day-2-c-reactive-protein-after-colon-cancer-surgery/Medxy AIen2026-10-15T12:04:21-07:00Early Identification of Low Anastomotic Leakage Risk Using Postoperative Day 2 C-Reactive Protein After Colon Cancer Surgery https://news.medxy.ai/ja/immunotherapy-rectal-cancer/Medxy AIja2026-10-15T12:03:35-07:002026年中国コンセンサスで変わる：局所進行直腸癌における免疫チェックポイント阻害薬の使い方 https://news.medxy.ai/vi/china-2026-consensus/Medxy AIvi2026-10-15T12:03:03-07:00Đồng thuận Trung Quốc 2026 đã thay đổi cách dùng thuốc ức chế điểm kiểm soát miễn dịch trong ung thư trực tràng tiến triển tại chỗ như thế nào https://news.medxy.ai/zh/2026-china-immunotherapy/Medxy AIzh2026-10-15T12:02:31-07:002026年中国共识如何重塑局部进展期直肠癌中免疫检查点抑制剂的应用 https://news.medxy.ai/how-the-2026-chinese-consensus-changes-use-of-immune-checkpoint-inhibitors-in-locally-advanced-rectal-cancer/Medxy AIen2026-10-15T12:02:04-07:00How the 2026 Chinese Consensus Changes Use of Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer https://news.medxy.ai/zh/stroke-related-vertigo/Medxy AIzh2026-10-15T12:00:52-07:00卒中相关眩晕的两种表型：急性失衡综合征与急性前庭综合征的临床与神经解剖学区分 https://news.medxy.ai/ja/stroke-dizziness-differences/Medxy AIja2026-10-15T12:00:34-07:00脳卒中関連めまいを見極める：急性平衡障害症候群と急性前庭症候群の違いを臨床と神経解剖から読み解く https://news.medxy.ai/vi/acute-vertigo-syndromes/Medxy AIvi2026-10-15T12:00:16-07:00Phân biệt Hội chứng mất thăng bằng cấp tính với Hội chứng tiền đình cấp tính trong chóng mặt do đột quỵ: Góc nhìn lâm sàng và thần kinh giải phẫu https://news.medxy.ai/differentiating-acute-imbalance-syndrome-from-acute-vestibular-syndrome-in-stroke-related-vertigo-clinical-and-neuroanatomical-insights/Medxy AIen2026-10-15T11:59:57-07:00Differentiating Acute Imbalance Syndrome from Acute Vestibular Syndrome in Stroke-Related Vertigo: Clinical and Neuroanatomical Insights https://news.medxy.ai/zh/insulin-therapy-night-nutrition/Medxy AIzh2026-10-15T11:59:18-07:00夜间肠外营养患者的胰岛素治疗：持续葡萄糖监测如何助力优化 https://news.medxy.ai/ja/cgm-insulin-optimization/Medxy AIja2026-10-15T11:59:00-07:00夜間静脈栄養患者におけるCGMを活用したインスリン治療最適化 https://news.medxy.ai/vi/insulin-optimization/Medxy AIvi2026-10-15T11:58:38-07:00Tối ưu hóa điều trị insulin bằng theo dõi glucose liên tục ở bệnh nhân nuôi dưỡng tĩnh mạch ban đêm https://news.medxy.ai/optimizing-insulin-therapy-with-continuous-glucose-monitoring-in-nocturnal-parenteral-nutrition-patients/Medxy AIen2026-10-15T11:58:20-07:00Optimizing Insulin Therapy with Continuous Glucose Monitoring in Nocturnal Parenteral Nutrition Patients